Crossmark

Cardiovascular and microvascular outcomes of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled cardiovascular outcome trials with trial sequential analysis

Crossref DOI link: https://doi.org/10.1186/s40360-018-0246-x

Published Online: 2018-09-17

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Xiaowen

Shao, Fei

Zhu, Lin

Ze, Yuyang

Zhu, Dalong

Bi, Yan http://orcid.org/0000-0003-3914-7854
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81800752)

Natural Science Foundation of Jiangsu Province (BK20170125)

Jiangsu Provincial Key Medical Discipline (ZDXKB2016012)

Key Research and Development Program of Jiangsu Province of China (BE2015604)

Key Research and Development Program of Jiangsu Province of China (BE2016606)
License Information

Text and Data Mining valid from 2018-09-17
More Information

Article History

Received: 24 May 2018

Accepted: 28 August 2018

First Online: 17 September 2018

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below